Next Article in Journal / Special Issue
In Silico Design of Natural Inhibitors of ApoE4 from the Plant Moringa oleifera: Molecular Docking and Ab Initio Fragment Molecular Orbital Calculations
Previous Article in Journal
A New 3D Iodoargentate Hybrid: Structure, Optical/Photoelectric Performance and Theoretical Research
Previous Article in Special Issue
Identification of Potential Modulators of a Pathogenic G Protein-Gated Inwardly Rectifying K+ Channel 4 Mutant: In Silico Investigation in the Context of Drug Discovery for Hypertension
 
 
Article
Peer-Review Record

In Silico Screening of Natural Flavonoids against 3-Chymotrypsin-like Protease of SARS-CoV-2 Using Machine Learning and Molecular Modeling

Molecules 2023, 28(24), 8034; https://doi.org/10.3390/molecules28248034
by Lianjin Cai †, Fengyang Han †, Beihong Ji, Xibing He, Luxuan Wang, Taoyu Niu, Jingchen Zhai and Junmei Wang *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Molecules 2023, 28(24), 8034; https://doi.org/10.3390/molecules28248034
Submission received: 7 November 2023 / Revised: 30 November 2023 / Accepted: 7 December 2023 / Published: 10 December 2023
(This article belongs to the Special Issue In Silico Methods Applied in Drug and Pesticide Discovery)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

In this manuscript, Cai et al. employ machine learning to screen natural flavonoids against the 3-Chymotrypsin-like Protease of SARS-CoV-2, aiming to discover new methods to combat SARS-CoV-2. They conduct the screening of 6001 flavonoids using ligand-residue energy interaction profiles (IPS). Eventually, they identify nine flavonoids that show potential effects against SARS-CoV-2. While their approach involves a large dataset and is operationally straightforward and rapid, I have reservations about the nine potential targets identified because the authors did not validate the actual effects of these flavonoids through biological experiments in the article.

The ultimate goal of such screenings is application, and the affinity analysis of drugs can only indicate potential therapeutic effects. Whether these effects truly exist needs confirmation through specific biological experiments. I recommend that the authors supplement their work with concrete experiments involving cells, mice, or clinical trials to demonstrate the efficacy of the nine identified targets before resubmitting the manuscript. Mere binding ability is insufficient.

Author Response

Dear Editors:

 

We sincerely thank the reviewers for careful reading of our manuscript and insightful suggestions on further improving the manuscript. We have addressed the minor issues, updated the references, and highlighted all revisions in the revised manuscript version.

 

 We have carefully revised the manuscript properly addressed both reviewers’ comments. Below, we detail our responses to each comment and the corresponding revisions made to the manuscript. The comments from the reviewers are shown in blue color, our response in black, and the revised text in red. 

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Please find attached.

Comments for author File: Comments.pdf

Author Response

Dear Editors:

 

We sincerely thank the reviewers for careful reading of our manuscript and insightful suggestions on further improving the manuscript. We have addressed the minor issues, updated the references, and highlighted all revisions in the revised manuscript version.

 

 We have carefully revised the manuscript properly addressed both reviewers’ comments. Below, we detail our responses to each comment and the corresponding revisions made to the manuscript. The comments from the reviewers are shown in blue color, our response in black, and the revised text in red. 

 

Author Response File: Author Response.pdf

Back to TopTop